From CRISIL
Alembic Pharmaceuticals has received revision in credit ratings from CRISIL as under -CRISIL has upgraded the Credit Rating of Long-term bank facilities from 'CRISIL AA/Positive' to 'CRISIL AA+/Stable' for Rs. 315 crore limit of fund/non-fund based facilities of the Company.
CRISIL has reaffirmed the Credit Rating of CRISIL A1+ (Short-term debt including Commercial Paper) for Rs. 200 crore limit of fund based facilities of the Company.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
